BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND PALB2, ENSG00000083093, 79728
13 results:

  • 1. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
    Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
    J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (palb2).
    McReynolds LJ; Biswas K; Giri N; Sharan SK; Alter BP
    Cancer Genet; 2021 Nov; 258-259():101-109. PubMed ID: 34687993
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A rare palb2 germline variant causing G2/M cell cycle arrest is associated with isolated myelosarcoma in infancy.
    Beer A; Beck R; Schedel A; von Bonin M; Meinel J; Friedrich UA; Menzel M; Suttorp M; Brenner S; Fitze G; Lange B; Knöfler R; Hauer J; Auer F
    Mol Genet Genomic Med; 2021 Sep; 9(9):e1746. PubMed ID: 34382369
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prevalence and clinical implications of germline predisposition gene mutations in patients with acute myeloid leukemia.
    Kim B; Yun W; Lee ST; Choi JR; Yoo KH; Koo HH; Jung CW; Kim SH
    Sci Rep; 2020 Aug; 10(1):14297. PubMed ID: 32868804
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Ablation of the Brca1-palb2 Interaction Phenocopies Fanconi Anemia in Mice.
    Park D; Bergin SM; Jones D; Ru P; Koivisto CS; Jeon YJ; Sizemore GM; Kladney RD; Hadjis A; Shakya R; Ludwig T
    Cancer Res; 2020 Oct; 80(19):4172-4184. PubMed ID: 32732220
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Tyrosine kinase inhibitor-induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors.
    Maifrede S; Nieborowska-Skorska M; Sullivan-Reed K; Dasgupta Y; Podszywalow-Bartnicka P; Le BV; Solecka M; Lian Z; Belyaeva EA; Nersesyan A; Machnicki MM; Toma M; Chatain N; Rydzanicz M; Zhao H; Jelinek J; Piwocka K; Sliwinski T; Stoklosa T; Ploski R; Fischer T; Sykes SM; Koschmieder S; Bullinger L; Valent P; Wasik MA; Huang J; Skorski T
    Blood; 2018 Jul; 132(1):67-77. PubMed ID: 29784639
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical characteristics and genetic subtypes of Fanconi anemia in Saudi patients.
    Ghazwani Y; AlBalwi M; Al-Abdulkareem I; Al-Dress M; Alharbi T; Alsudairy R; Alomari A; Aljamaan K; Essa M; Al-Zahrani M; Alsultan A
    Cancer Genet; 2016 Apr; 209(4):171-6. PubMed ID: 26968956
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Patterns and functional implications of rare germline variants across 12 cancer types.
    Lu C; Xie M; Wendl MC; Wang J; McLellan MD; Leiserson MD; Huang KL; Wyczalkowski MA; Jayasinghe R; Banerjee T; Ning J; Tripathi P; Zhang Q; Niu B; Ye K; Schmidt HK; Fulton RS; McMichael JF; Batra P; Kandoth C; Bharadwaj M; Koboldt DC; Miller CA; Kanchi KL; Eldred JM; Larson DE; Welch JS; You M; Ozenberger BA; Govindan R; Walter MJ; Ellis MJ; Mardis ER; Graubert TA; Dipersio JF; Ley TJ; Wilson RK; Goodfellow PJ; Raphael BJ; Chen F; Johnson KJ; Parvin JD; Ding L
    Nat Commun; 2015 Dec; 6():10086. PubMed ID: 26689913
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia.
    Churpek JE; Marquez R; Neistadt B; Claussen K; Lee MK; Churpek MM; Huo D; Weiner H; Bannerjee M; Godley LA; Le Beau MM; Pritchard CC; Walsh T; King MC; Olopade OI; Larson RA
    Cancer; 2016 Jan; 122(2):304-11. PubMed ID: 26641009
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
    Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Heterozygote FANCD2 mutations associated with childhood T Cell ALL and testicular seminoma.
    Smetsers S; Muter J; Bristow C; Patel L; Chandler K; Bonney D; Wynn RF; Whetton AD; Will AM; Rockx D; Joenje H; Strathdee G; Shanks J; Klopocki E; Gille JJ; Dorsman J; Meyer S
    Fam Cancer; 2012 Dec; 11(4):661-5. PubMed ID: 22829014
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cancer incidence in relatives of British Fanconi Anaemia patients.
    Tischkowitz M; Easton DF; Ball J; Hodgson SV; Mathew CG
    BMC Cancer; 2008 Sep; 8():257. PubMed ID: 18786261
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The Fanconi anemia pathway and ubiquitin.
    Jacquemont C; Taniguchi T
    BMC Biochem; 2007 Nov; 8 Suppl 1(Suppl 1):S10. PubMed ID: 18047734
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.